Bristol Myers Squibb to Participate in Upcoming Investor Conferences
May 07 2024 - 5:59AM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will participate in two upcoming investor conferences in
May 2024.
Ben Hickey, President, RayzeBio, Head of Mirati, will take part
in a fireside chat at the Guggenheim Healthcare Talks
Radiopharmaceuticals Day on Monday, May 13, 2024. He will answer
questions about the company beginning at 11:00 a.m. ET.
David Elkins, Executive Vice President, Chief Financial Officer,
will participate in a fireside chat at the 2024 Bank of America
Global Healthcare Conference on Wednesday, May 15, 2024. He will
answer questions about the company beginning at 11:20 a.m. PT/2:20
p.m. ET.
Investors and the general public are invited to listen to both
sessions at their respective times by visiting
http://investor.bms.com. An archived edition of each session will
be available following its conclusion.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop, and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507673830/en/
Media: media@bms.com Investors:
investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2024 to May 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From May 2023 to May 2024
